Bruker Common Stock Net 2010-2025 | BRKR

Bruker common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
  • Bruker common stock net for the quarter ending March 31, 2025 was $2M, a 5.88% increase year-over-year.
  • Bruker common stock net for 2024 was $0.002B, a 5.88% increase from 2023.
  • Bruker common stock net for 2023 was $0.002B, a 0% decline from 2022.
  • Bruker common stock net for 2022 was $0.002B, a 0% decline from 2021.
Bruker Annual Common Stock Net
(Millions of US $)
2024 $2
2023 $2
2022 $2
2021 $2
2020 $2
2019 $2
2018 $2
2017 $2
2016 $2
2015 $2
2014 $2
2013 $2
2012 $2
2011 $2
2010 $2
2009 $2
Bruker Quarterly Common Stock Net
(Millions of US $)
2025-03-31 $2
2024-12-31 $2
2024-09-30 $2
2024-06-30 $2
2024-03-31 $2
2023-12-31 $2
2023-09-30 $2
2023-06-30 $2
2023-03-31 $2
2022-12-31 $2
2022-09-30 $2
2022-06-30 $2
2022-03-31 $2
2021-12-31 $2
2021-09-30 $2
2021-06-30 $2
2021-03-31 $2
2020-12-31 $2
2020-09-30 $2
2020-06-30 $2
2020-03-31 $2
2019-12-31 $2
2019-09-30 $2
2019-06-30 $2
2019-03-31 $2
2018-12-31 $2
2018-09-30 $2
2018-06-30 $2
2018-03-31 $2
2017-12-31 $2
2017-09-30 $2
2017-06-30 $2
2017-03-31 $2
2016-12-31 $2
2016-09-30 $2
2016-06-30 $2
2016-03-31 $2
2015-12-31 $2
2015-09-30 $2
2015-06-30 $2
2015-03-31 $2
2014-12-31 $2
2014-09-30 $2
2014-06-30 $2
2014-03-31 $2
2013-12-31 $2
2013-09-30 $2
2013-06-30 $2
2013-03-31 $2
2012-12-31 $2
2012-09-30 $2
2012-06-30 $2
2012-03-31 $2
2011-12-31 $2
2011-09-30 $2
2011-06-30 $2
2011-03-31 $2
2010-12-31 $2
2010-09-30 $2
2010-06-30 $2
2010-03-31 $2
2009-12-31 $2
2009-09-30 $2
2009-06-30 $2
2009-03-31 $2
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $6.243B $3.366B
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
Stock Name Country Market Cap PE Ratio
Kewaunee Scientific (KEQU) United States $0.168B 10.91
Harvard Bioscience (HBIO) United States $0.020B 0.00